Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Prasugrel Could Avoid More Restrictive REMS Options, Lilly Hints

Jul 28 2008

• By Cathy Dombrowski

Related Content

Lilly Prasugrel Beats Plavix In TRITON, But Bleeding Data Raise Questions

Nov 12 2007

FDA’s Strongest REMS To Date: Entereg Approved With Controlled-Distribution

May 26 2008

Bristol Readies For Prasugrel’s Impact On Plavix, Files DPP-4 Inhibitor

Jul 28 2008

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window